Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer(Scientific Reports (2015) 5: (10442) 10.1038/srep10442);A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Al Tassan, Nada A ^a   Whiffin, Nicola ^b   Hosking, Fay J ^b   Palles, Claire ^c   Farrington, Susan M ^d   Dobbins, Sara E ^b   Harris, Rebecca ^e   Gorman, Maggie ^c   Tenesa, Albert ^d,f   Meyer, Brian F ^a   Wakil, Salma M ^a   Kinnersley, Ben ^b   Campbell, Harry ^d   Martin, Lynn ^c   Smith, Christopher G ^e   Idziaszczyk, Shelley ^e   Barclay, Ella ^c   Maughan, Timothy S ^g   Kaplan, Richard ^h   Kerr, Rachel ^g   Kerr, David ^g   Buchannan, Daniel D ⁱ   Ko Win, Aung ⁱ   Hopper, John ⁱ   Jenkins, Mark ⁱ   Lindor, Noralane M ^j   Newcomb, Polly A ^k   Gallinger, Steve ^l   Conti, David ^m   Schumacher, Fred ^m   Casey, Graham ^m   Dunlop, Malcolm G ^d   Tomlinson, Ian P ^c   Cheadle, Jeremy P ^e   Houlston, Richard S ^b   more..

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h MRC CLINICAL TRIALS UNIT   (United Kingdom)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j MAYO CLINIC   (United States)

^k USA   (United States)

^l MOUNT SINAI HOSPITAL   (Canada)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; FORKHEAD TRANSCRIPTION FACTOR; FOXL1 PROTEIN, HUMAN; INTRINSIC FACTOR-COBALAMIN RECEPTOR; TUMOR MARKER;

CHROMOSOMAL MAPPING; COLORECTAL TUMOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOMARKERS, TUMOR; CHROMOSOME MAPPING; COLORECTAL NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE;

EID: 84930225190     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12372     Document Type: Erratum

References (62)

1. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78-85 (2000).
2. Aaltonen, L., Johns, L., Jarvinen, H., Mecklin, J. P. & Houlston, R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin. Cancer Res. 13, 356-361 (2007).
3. Lubbe, S. J., Webb, E. L., Chandler, I. P. & Houlston, R. S. Implications of familial colorectal cancer risk profiles and microsatellite instability status. J. Clin. Oncol. 27, 2238-2244 (2009).
4. Broderick, P. et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet. 39, 1315-1317 (2007).
5. Dunlop, M. G. et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat. Genet. 44, 770-776 (2012).
6. Houlston, R. S. et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet. 42, 973-977 (2010).
7. Peters, U. et al. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology 144, 799-807 (2013).
8. Tenesa, A. et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet. 40, 631-637 (2008).
9. Tomlinson, I. et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39, 984-988 (2007).
10. Tomlinson, I. P. et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet. 40, 623-630 (2008).
11. Tomlinson, I. P. et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet. 7, e1002105 (2011).
12. Whiffin, N. et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Hum. Mol. Genet. 23, 4729-4737 (2014).
13. Cui, R. et al. Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population. Gut 60, 799-805 (2011).
14. Jia, W. H. et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat. Genet. 45, 191-196 (2013).
15. Wang, H. et al. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat. Commun. 5, 4613 (2014).
16. Zhang, B. et al. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk. Nat. Genet. 46, 533-542 (2014).
17. The 1000 Genomes Project Consortium et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 491, 56-65 (2012).
18. Maughan, T. S. et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet 377, 2103-2114 (2011).
19. Midgley, R. S. et al. Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. J. Clin. Oncol. 28, 4575-4580 (2010).
20. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41 (2006).
21. Newcomb, P. A. et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol. Biomarkers Prev. 16, 2331-2343 (2007).
22. Hunter, D. J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874 (2007).
23. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649 (2007).
24. R Core Team 2013. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/(Date of access 01/12/2014); (Accessed 01/12/2014).
25. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J. Hum. Genet. 81, 559-575 (2007).
26. Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179-181 (2012).
27. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genomewide association studies. PLoS Genet 5, e1000529 (2009).
28. 1000 Genomes. http://www.1000genomes.org/(Accessed 01/12/2014)
29. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet 39, 906-913 (2007).
30. Liu, J. Z. et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 42, 436-440 (2010).
31. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002).
32. Pharoah, P. D., Antoniou, A. C., Easton, D. F. & Ponder, B. A. Polygenes, risk prediction, and targeted prevention of breast cancer. N. Engl. J. Med. 358, 2796-2803 (2008).
33. Johns, L. E. & Houlston, R. S. A systematic review and meta-analysis of familial colorectal cancer risk. Am. J. Gastroenterol. 96, 2992-3003 (2001).
34. Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 28, 817-825 (2010).
35. The ENCODE Project: ENCyclopedia Of DNA Elements. http://www.genome.gov/encode/(Accessed 01/12/2014).
36. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310-315 (2014).
37. Cooper, G. M. et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome. Res. 15, 901-913 (2005).
38. The Cancer Genome Atlas http://cancergenome.nih.gov/(Accessed 01/12/2014).
39. Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, 11 (2013).
40. Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404 (2012).
41. Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495-501 (2014).
42. NCI pathway interaction database. Accessed 01/12/2014. http://pid.nci.nih.gov/(2014).
43. Boland, C. R. et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257 (1998).
44. Smith, C. G. et al. Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy cetuximab. Clin. Cancer Res. 19, 4104-4113 (2013).
45. Wasan, H. et al. Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial. Lancet Oncol. 15, 631-639 (2014).
46. Clayton, D. G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet. 37, 1243-1246 (2005).
47. Broderick, P. et al. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer. Res. 69, 6633-6641 (2009).
48. Migliorini, G. et al. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood 122, 3298-3307 (2013).
49. Chubb, D. et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat. Genet. 45, 1221-1225 (2013).
50. Sanson, M. et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum. Mol. Genet. 20, 2897-2904 (2011).
51. Dobbins, S. E. et al. Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat. Genet. 43, 825-827 (2011).
52. Guo, X. et al. Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev. 18, 2404-2417 (2004).
53. Wu, W. J., Erickson, J. W., Lin, R. & Cerione, R. A. The gamma-subunit of the coatomer complex binds Cdc42 to mediate transformation. Nature 405, 800-804 (2000).
54. Leve, F. & Morgado-Diaz, J. A. Rho GTPase signaling in the development of colorectal cancer. J. Cell Biochem. 113, 2549-2559 (2012).
55. Gao, L., Bai, L. & Nan, Q. Activation of Rho GTPase Cdc42 promotes adhesion and invasion in colorectal cancer cells. Med. Sci. Monit Basic Res. 19, 201-207 (2013).
56. Zins, K., Gunawardhana, S., Lucas, T., Abraham, D. & Aharinejad, S. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity. J. Transl. Med. 11, 295 (2013).
57. Kozyraki, R. et al. The human intrinsic factor-vitamin B12 receptor, cubilin: molecular characterization and chromosomal mapping of the gene to 10p within the autosomal recessive megaloblastic anemia (MGA1) region. Blood 91, 3593-3600 (1998).
58. Nykjaer, A. et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc. Natl. Acad. Sci. USA 98, 13895-13900 (2001).
59. Bassett, J. K. et al. Dietary intake of B vitamins and methionine and colorectal cancer risk. Nutr. Cancer 65, 659-667 (2013).
60. Razzak, A. A. et al. Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr. Cancer 64, 899-910 (2012).
61. Zhai, H. et al. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin. Colorectal. Cancer 12, 261-266 (2013).
62. Ling, H. et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 23, 1446-1461 (2013).